TNFRSF10B and cancer: For example, downregulation of TRAIL death receptors DR4 and DR5, overexpression of negative regulators of apoptosis Bcl-2 or Bcl-X(L), and mutations in Bax, Bak, cFLIP, and caspase-8 have been reported to cause TRAIL resistance in various cancer cells [10].